| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0065 | 0.9 |